176 related articles for article (PubMed ID: 21551338)
1. Bisphosphonates inhibit expression of p63 by oral keratinocytes.
Scheller EL; Baldwin CM; Kuo S; D'Silva NJ; Feinberg SE; Krebsbach PH; Edwards PC
J Dent Res; 2011 Jul; 90(7):894-9. PubMed ID: 21551338
[TBL] [Abstract][Full Text] [Related]
2. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
Scheper MA; Badros A; Chaisuparat R; Cullen KJ; Meiller TF
Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?
Brown JJ; Ramalingam L; Zacharin MR
Clin Endocrinol (Oxf); 2008 Jun; 68(6):863-7. PubMed ID: 18221397
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
Murad OM; Arora S; Farag AF; Guber HA
Endocr Pract; 2007; 13(3):232-8. PubMed ID: 17599853
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
6. Importance of microcracks in etiology of bisphosphonate-related osteonecrosis of the jaw: a possible pathogenetic model of symptomatic and non-symptomatic osteonecrosis of the jaw based on scanning electron microscopy findings.
Hoefert S; Schmitz I; Tannapfel A; Eufinger H
Clin Oral Investig; 2010 Jun; 14(3):271-84. PubMed ID: 19536569
[TBL] [Abstract][Full Text] [Related]
7. Compromised osseous healing of dental extraction sites in zoledronic acid-treated dogs.
Allen MR; Kubek DJ; Burr DB; Ruggiero SL; Chu TM
Osteoporos Int; 2011 Feb; 22(2):693-702. PubMed ID: 20458574
[TBL] [Abstract][Full Text] [Related]
8. Early appearance of osteonecrosis of the jaw after zoledronic acid in a patient with a long history of taking oral bisphosphonates.
Uña E
BMJ Case Rep; 2012 Mar; 2012():. PubMed ID: 22605820
[TBL] [Abstract][Full Text] [Related]
9. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonate effects on the behaviour of oral epithelial cells and oral fibroblasts.
Ravosa MJ; Ning J; Liu Y; Stack MS
Arch Oral Biol; 2011 May; 56(5):491-8. PubMed ID: 21146154
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
Cetiner S; Sucak GT; Kahraman SA; Aki SZ; Kocakahyaoglu B; Gultekin SE; Cetiner M; Haznedar R
J Bone Miner Metab; 2009; 27(4):435-43. PubMed ID: 19240969
[TBL] [Abstract][Full Text] [Related]
12. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
13. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: how the knowledge of a phenomenon can change its evolution.
La Verde N; Bareggi C; Garassino M; Borgonovo K; Sburlati P; Pedretti D; Bianchi C; Perrone S; Mihali D; Cobelli S; Mantica C; Rizzo A; Farina G
Support Care Cancer; 2008 Nov; 16(11):1311-5. PubMed ID: 18663482
[TBL] [Abstract][Full Text] [Related]
16. Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial.
Grbic JT; Landesberg R; Lin SQ; Mesenbrink P; Reid IR; Leung PC; Casas N; Recknor CP; Hua Y; Delmas PD; Eriksen EF;
J Am Dent Assoc; 2008 Jan; 139(1):32-40. PubMed ID: 18167382
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Bamias A; Kastritis E; Bamia C; Moulopoulos LA; Melakopoulos I; Bozas G; Koutsoukou V; Gika D; Anagnostopoulos A; Papadimitriou C; Terpos E; Dimopoulos MA
J Clin Oncol; 2005 Dec; 23(34):8580-7. PubMed ID: 16314620
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
19. Osteonecrosis of the jaws in patients with bone metastasis receiving intravenous bisphosphonates. A rising concern.
Aguiar Bujanda D; Cabrera Suárez MA; Bohn Sarmiento U; Quintero Pérez S; Aguiar Morales J
Clin Transl Oncol; 2006 Dec; 8(12):919-21. PubMed ID: 17169767
[TBL] [Abstract][Full Text] [Related]
20. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
